A rice suspension cell according to an embodiment is useful for producing recombinant canine or feline albumin at high efficiency, and thus, by culturing the rice suspension cell, a large amount of recombinant canine or feline albumin can be safely produced at high efficiency. Moreover, it is expected that the veterinary composition for preventing, ameliorating, or treating hypoalbuminemia comprising the rice suspension cell of the present invention would greatly contribute to the resolving of the problems related to safety, social controversies, or the like that are caused by prescribing human serum albumin in veterinary care practice.

The present invention relates to a novel bacteriophage CJ25 (KCCM11463P) and a composition comprising the same as an active ingredient. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by avian pathogenic Escherichia coli (APEC) of birds by using the bacteriophage CJ25 (KCCM11463P) or the composition.

The present invention relates to a novel bacteriophage CJ25 (KCCM11463P) and a composition comprising the same as an active ingredient. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by avian pathogenic Escherichia coli (APEC) of birds by using the bacteriophage CJ25 (KCCM11463P) or the composition.

The present invention relates to a novel bacteriophage CJ24 (KCCM11462P) and a composition comprising the same as an active component. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by avian pathogenic E. coli of birds by using the bacteriophage CJ24 (KCCM11462P) or the composition.

The present invention relates to a novel bacteriophage CJ24 (KCCM11462P) and a composition comprising the same as an active component. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by avian pathogenic E. coli of birds by using the bacteriophage CJ24 (KCCM11462P) or the composition.

The present invention relates to a composition using a SLIT-ROBO system for preventing or treating sarcopenia and, more specifically, to a composition comprising a gene selected from among slit1, slit2, slit3, robo1, robo2, and fragments thereof, or a protein expressed from the gene as an effective ingredient for preventing or treating a muscle disease or for improving muscular function.

Provided herein is a process for increasing the dissolution rate of a sparingly water soluble flavor or taste modifying compound in water comprising: a. mixing the compound and a highly water soluble second compound in a water based solution to form a solution or dispersion of the compound; and b. drying the solution or dispersion to form a solution or solid dispersion of the compound wherein the compound has an increased dissolution rate in water as compared to the compound when dissolved in water alone.

The present invention relates to processes for extracting lipid from vegetative plant parts such as leaves, stems, roots and tubers, and for producing industrial products such as hydrocarbon products from the lipids. Preferred industrial products include alkyl esters which may be blended with petroleum based fuels.

The present invention relates to processes for extracting lipid from vegetative plant parts such as leaves, stems, roots and tubers, and for producing industrial products such as hydrocarbon products from the lipids. Preferred industrial products include alkyl esters which may be blended with petroleum based fuels.

The present invention relates to a novel bacteriophage CJ25 (KCCM11463P) and a composition comprising the same as an active ingredient. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by avian pathogenic Escherichia coli (APEC) of birds by using the bacteriophage CJ25 (KCCM11463P) or the composition.